October 22, 2015
8:00 a.m. - 10:00 a.m.
In an era of personalization -- where music apps filter songs based on listener preferences and online ads populated based on user search history -- healthcare is the next frontier.
Scientific advances are transforming healthcare and ushering in a new era of personalized – or precision – medicine. This approach makes it possible to account for each patient’s genetics, health history and lifestyle as researchers develop and doctors prescribe individualized treatments.
Such data-driven medicine has far-reaching policy implications, from regulations to delivery systems.
October 22nd, join The Hill for a discussion on the impact of this
emerging field, the challenges to its progress, and how the Precision
Medicine Initiative fits into the complex personalized medicine
Kathy Hudson, Ph.D.
Deputy Director for Science, Outreach and Policy
National Institutes of Health [NIH]
Elizabeth Mansfield, Ph.D.
Director of Personalized Medicine in the Office of In Vitro Diagnostics Device Evaluation & Safety, Center for Devices and Radiological Health
Food & Drug Administration [FDA]